570
Views
13
CrossRef citations to date
0
Altmetric
Scientific Articles

Pharmacokinetics and estimated bioavailability of grapiprant, a novel selective prostaglandin E2 receptor antagonist, after oral administration in fasted and fed dogs

, , , , &
Pages 19-23 | Received 07 May 2016, Accepted 21 Sep 2016, Published online: 19 Oct 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Marike Visser, Matthew J. Zaya, Charles W. Locuson, Dawn M. Boothe & Dawn A. Merritt. (2019) Comparison of predicted intrinsic hepatic clearance of 30 pharmaceuticals in canine and feline liver microsomes. Xenobiotica 49:2, pages 177-186.
Read now

Articles from other publishers (12)

Stephanie Kleine, Chiara E. Hampton, Christopher Smith, Genevieve Bussieres, Pierre‐Yves Mulon, Reza Seddighi, Sherry Cox & Joe Smith. (2023) Pharmacokinetics of a single oral dose of grapiprant in juvenile pigs ( Sus scrofa domestica ) . Journal of Veterinary Pharmacology and Therapeutics 46:5, pages 269-275.
Crossref
Juliet M. Ross, Stephanie A. Kleine, Christopher K. Smith, Rebekah K. DeBolt, Jennifer Weisent, Emma Hendrix & Reza Seddighi. (2022) Evaluation of the perioperative analgesic effects of grapiprant compared with carprofen in dogs undergoing elective ovariohysterectomy. Journal of the American Veterinary Medical Association, pages 1-8.
Crossref
Silke L. Hoffmann, Kelsey Seminoff, Daniel S. McKemie, Philip H. Kass & Heather K. Knych. (2022) Pharmacokinetics of grapiprant and effects on TNF ‐alpha concentrations following oral administration to horses . Journal of Veterinary Pharmacology and Therapeutics 45:5, pages 467-472.
Crossref
Jennifer Halleran, Geraldine Magnin, Danielle Mzyk, Sally Venable, Robert Streeter & Johann Coetzee. (2021) Pharmacokinetics of grapiprant in goat kids at two different dosing regimens. Small Ruminant Research 205, pages 106531.
Crossref
Mark C. Heit, Katrina L. Mealey & Stephen B. King. (2021) Tolerance and Pharmacokinetics of Galliprant™ Administered Orally to Collies Homozygous for MDR1‐1Δ. Journal of Veterinary Pharmacology and Therapeutics 44:5, pages 705-713.
Crossref
Irene Sartini & Mario Giorgi. (2021) Grapiprant: A snapshot of the current knowledge. Journal of Veterinary Pharmacology and Therapeutics 44:5, pages 679-688.
Crossref
Beata Łebkowska‐Wieruszewska, Małgorzata Gbylik‐Sikorska, Anna Gajda, Irene Sartini, Andrzej Lisowski, Amnart Poapolathep & Mario Giorgi. (2021) Cebranopadol, a novel first‐in‐class drug candidate: Method validation and first exploratory pharmacokinetic study in rabbits. Journal of Veterinary Pharmacology and Therapeutics 44:4, pages 516-521.
Crossref
Sherry Cox, Carla Sommardahl, Chelsey Fortner, Rebecca Davis, Joan Bergman & Tom Doherty. (2020) Determination of grapiprant plasma and urine concentrations in horses. Veterinary Anaesthesia and Analgesia 47:5, pages 705-709.
Crossref
Heather K. Knych, Kelsey Seminoff & Dan S. McKemie. (2018) Detection and pharmacokinetics of grapiprant following oral administration to exercised Thoroughbred horses. Drug Testing and Analysis 10:8, pages 1237-1243.
Crossref
B. Lebkowska‐Wieruszewska, V. De Vito, H. Owen, A. Poapholatep & M. Giorgi. (2017) Pharmacokinetics of grapiprant, a selective EP 4 prostaglandin PGE 2 receptor antagonist, after 2 mg/kg oral and i.v. administrations in cats . Journal of Veterinary Pharmacology and Therapeutics 40:6.
Crossref
Derek Adrian, Mark Papich, Ron Baynes, Jo Murrell & B. Duncan X. Lascelles. (2017) Chronic maladaptive pain in cats: A review of current and future drug treatment options. The Veterinary Journal 230, pages 52-61.
Crossref
V. De Vito, M. Salvadori, A. Poapolathep, H. Owen, R. Rychshanova & M. Giorgi. (2016) Pharmacokinetic/pharmacodynamic evaluation of grapiprant in a carrageenan‐induced inflammatory pain model in the rabbit. Journal of Veterinary Pharmacology and Therapeutics 40:5, pages 468-475.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.